Regulatory troubles continue for Sun Pharma as the drug manufacturer’s Mumbai unit has been issued an "official action indicated" (OAI) tag by the US Food and Drug Administration, which may ...
Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
Dadra's specialization lies in the production of oral solid dosage forms and the manufacture of the blockbuster drug Revlimid, a vital revenue driver for Sun Pharma's generics segment. The ...
The FDA said U.S. healthcare workers should avoid all plastic syringes manufactured by Jiangsu Shenli Medical Production as the agency investigates multiple syringe suppliers. In two import alerts ...
Sun Pharmaceutical Industries witnessed a 3.4% decline in its shares as the US FDA categorized its Dadra facility as 'official action indicated' (OAI), suggesting recommended regulatory or ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
It usually goes without saying that your pharmaceutical production workers need to be gowned and gloved while handling drug materials inside clean rooms. And, at the bare minimum, those workers ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
The Central Drugs Standard Control Organisation (CDSCO) has issued an alert against 58 samples of commonly used medicines as they failed the latest drug safety alert issued by the drug regulator ...
Stock Market Today- Sun Pharmaceutical Industries share price has decline 4-5% in last two trading sessions on regulatory concerns. The US drug regulator (USFDA) post conducting an inspection at ...